市場調查報告書
商品編碼
1248100
美國宮內節育器(宮內節育器)市場:規模、副產品(銅宮內節育器、激素宮內節育器)、年齡組、行業分析報告、區域展望、增長潛力、競爭市場份額和預測,2023-2032 年U.S. Intrauterine Devices Market Size, By Product (Copper IUD, Hormonal IUD), By Age Group (15-19, 20-24, 25-29, 30-34, 35-39, 40-44, 45+), Industry Analysis Report, Zonal Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032 |
在美國,宮內節育器市場預計將在 2023 年至 2032 年之間增長,原因是對宮內節育器使用的認識有所提高,尤其是女性。
使用此類避孕藥具可提高患者依從性,易於使用和維護,並可提高有效避孕率。
小型無焰銅和左炔諾孕酮釋放裝置,以及最近宮內節育技術的創新,可能有助於增加青少年和未婚女性對宮內節育器的使用。 此外,該國的一些政府和非政府組織正在努力提高人們對避孕藥具(包括宮內節育器)重要性的認識,從而提高企業利潤。
總體而言,美國宮內節育器行業按產品、年齡段和地區進行細分。
基於產品,含銅宮內節育器部分預計將在 2032 年出現顯著增長。 宮內節育器已被證明可以避孕 10 年,並已證明其避孕效果超過 99%,並且有望在未來變得更加流行。
按年齡劃分,預計 20-24 歲人群在 2023-2022 年的複合年增長率將超過 9.5%。 計劃晚孕的成年女性越來越多地採用宮內節育器,這將在未來十年推動這一細分市場的增長。 此外,長期妊娠預防、安全有效宮內節育器的使用增加以及異位妊娠機率降低等變量可能會在估計的時期內加速該年齡組的產品採用。
預計從 2023 年到 2032 年,美國東北部的宮內節育器市場將出現顯著增長。 該地區意外懷孕和相關健康危害的增加以及對有效避孕藥具的日益偏好正在推動業務擴張。
此外,由於該地區的高墮胎率和醫療保健政策,住院率上升也將提振該行業的前景。 根據古特馬赫研究所的預測,2020 年新澤西州進行了大約 48,830 例墮胎。 此外,中央政府針對青年開展的幾項關於宮內避孕藥和性健康的公眾意識活動預計將進一步推動市場增長。
U.S. Intrauterine Devices Market is estimated to grow during 2023-2032 owing to an increasing awareness regarding the use of such devices, especially among the American female population. Implementation of such devices for birth control offers enhanced patient compliance, ease of use, and low maintenance, while increasing the rate of effective contraception.
Smaller frameless copper and levonorgestrel-releasing devices, along with recent innovations in intrauterine technology, may contribute to a rise in the usage of IUDs among teenagers and nulliparous women. Besides, several government and non-government organizations in the republic are also working on spreading awareness regarding the significance of contraceptive products, including IUDs, thus propelling the business revenue.
Overall, the U.S. intrauterine devices industry is segmented in terms of product, age group, and zone.
Based on the product, the copper IUD segment will exhibit considerable growth during 2032. A thin copper wire used in Copper's IUD loops around the "tstem." The IUD prevents conception for a period of ten years, proving to be more than 99% effective at preventing pregnancy, thus increasing its penetration in the years to come.
Considering the age, the 20-24 age group segment is anticipated to depict over 9.5% CAGR between 2023-2022. Increasing adoption of IUDs among adult women owing to planned delayed pregnancies will assist the segmental growth over the next 10 years. In addition, variables such as preventing pregnancy for a long time, increasing the availability of safe & effective intrauterine devices, and decreasing the chances of ectopic pregnancy will most likely accelerate the product adoption rate among this age group during the estimated timeframe.
Considering the zone, the Northeast U.S. intrauterine devices market will register strong gains during 2023-2032. A mounting number of unintended pregnancies and related health consequences coupled with the rising preference for highly effective contraceptive options in the zone will impel the business expansion.
Moreover, the increasing rate of hospitalization owing to the high incidences of abortion and supportive healthcare policies in the zone will also favor the industry outlook. According to the Guttmacher Institute projections, approximately 48,830 abortions took place in New Jersey in 2020. Moreover, several awareness initiatives taken by the central government for young adults concerning intrauterine devices and sexual health would further thrive the market growth substantially.